Citation Impact
Citing Papers
Partial Surgical Removal of Growth Hormone-Secreting Pituitary Tumors Enhances the Response to Somatostatin Analogs in Acromegaly
2006
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
2007
Health benefits of physical activity: the evidence
2006 Standout
Acromegaly
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: A prospective, long-term study
2005
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
Thyroid cancer
2016 Standout
Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: A prospective study
2006
Long-term Fracture Risk in Patients with Celiac Disease: A Population-Based Study in Olmsted County, Minnesota
2007
Guidelines on the radical management of patients with lung cancer
2010
Nonsurgical approaches to the management of thyroid nodules
2006
Thyroid-hormone therapy and thyroid cancer: a reassessment
2005
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Medical Treatment of Cushing's Disease
2013
The Oslo definitions for coeliac disease and related terms
2012 Standout
Consequences of testing for celiac disease
2005
American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease
2006
Value of FDG PET Imaging in the Management of Patients With Thyroid, Neuroendocrine, and Neural Crest Tumors
2004
Metabolic osteopathy in celiac disease: importance of a gluten-free diet
2009
Osteoporosis: now and the future
2011 Standout
Osteoporosis in a North American adult population with celiac disease1
2001
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
2005
Celiac Disease
2007 Standout
Osteoporosis in adult patients with celiac disease
1999
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Improved Quality of Life After Bilateral Laparoscopic Adrenalectomy for Cushing's Disease
2007
Primary Treatment of Acromegaly with Octreotide LAR: A Long-Term (Up to Nine Years) Prospective Study of Its Efficacy in the Control of Disease Activity and Tumor Shrinkage
2006
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Menstrual disorders in adolescence: investigation and management
2003
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Patient Perception of Treatment Burden Is High in Celiac Disease Compared With Other Common Conditions
2014
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
AGA technical review on osteoporosis in gastrointestinal diseases
2003
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Osteoporosis in Cushing�s Syndrome
2002
Outcome of Cabergoline Treatment in Men with Prolactinoma: Effects of a 24-Month Treatment on Prolactin Levels, Tumor Mass, Recovery of Pituitary Function, and Semen Analysis
2004
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area
2003
Primary hyperparathyroidism and the skeleton
2008
Growth-hormone and prolactin excess
1998
Evidence of poor vitamin status in coeliac patients on a gluten‐free diet for 10 years
2002
Hyperprolactinemia and Prolactinomas
2008
Neuroblastoma
2007 Standout
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Bone mineral density at diagnosis and following successful treatment of pediatric Cushing’s disease
2005
Bone in celiac disease
2008
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents
2009
Subclinical Hyperthyroidism and Pregnancy Outcomes
2006
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Cushing's syndrome
2006 Standout
Glucocorticoid-induced osteoporosis
2000
The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics
2011
Drug Insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women
2006
Polycystic ovary syndrome
2016 Standout
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
2004
Growth hormone and the heart
2001
Systematic review: the evidence base for long‐term management of coeliac disease
2008
Should ‘low‐risk’ thyroid cancer patients with residual thyroglobulin be re‐treated with iodine 131?
2006
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Thyroid-Disrupting Chemicals: Interpreting Upstream Biomarkers of Adverse Outcomes
2009
Clinical Benefit of a Gluten-Free Diet in Type 1 Diabetic Children With Screening-Detected Celiac Disease
2006 StandoutNobel
Screening for Celiac Disease in Children With Type 1 Diabetes
2003
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Nephrolithiasis in Cushing’s Disease: Prevalence, Etiopathogenesis, and Modification after Disease Cure
2003
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
State-of-the-science of endocrine disrupting chemicals, 2012
2012
Osteoporosis Is More Prevalent in Adrenal than in Pituitary Cushing's Syndrome.
2003
Advances in the Treatment of Prolactinomas
2006
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
2013
De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma
2008
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Cancer treatment and survivorship statistics, 2019
2019 Standout
Iron-Deficiency Anemia
2015 Standout
Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
2004
The Halogen Bond
2016 Standout
Endocrinological Disorders and Celiac Disease
2002
Benign and Malignant Pheochromocytoma
1998
Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma
2004
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
2015 StandoutNobel
Works of Michele Klain being referenced
Severe impairment of bone mass and turnover in Cushing’s disease: comparison between childhood‐onset and adulthood‐onset disease
2002
Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans
1996
Growth Hormone Deficiency in Elderly Patients with Hypothalamo-Pituitary Tumors
1998
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization
2000
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease
1998
The use of recombinant human TSH in the follow‐up of differentiated thyroid cancer: experience from a large patient cohort in a single centre
2002
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment
2005
The role of radiolabeled somatostatin analogs in adrenal imaging
1996
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study
2003
Bone Demineralization and Vertebral Fractures in Endogenous Cortisol Excess: Role of Disease Etiology and Gonadal Status
2006
Subclinical hyperthyroidism: clinical features and treatment options
2005
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours
2002
Effect of a Short-Term Treatment with Alendronate on Bone Density and Bone Markers in Patients with Central Diabetes Insipidus
1999
Radioiodine therapy for papillary and follicular thyroid carcinoma
2002
Relationship Between Tumor Burden and Serum Thyroglobulin Level in Patients with Papillary and Follicular Thyroid Carcinoma
2002
Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response.
1997
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
2004
Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males
1998
Follow-up of differentiated thyroid carcinoma.
2004
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
2001
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
2008
Cardiovascular Safety of Acute Recombinant Human Thyrotropin Administration to Patients Monitored for Differentiated Thyroid Cancer
2003